%0 Journal Article
%T ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.
%A Simmonds NJ
%A Southern KW
%A De Wachter E
%A De Boeck K
%A Bodewes F
%A Mainz JG
%A Middleton PG
%A Schwarz C
%A Vloeberghs V
%A Wilschanski M
%A Bourrat E
%A Chalmers JD
%A Ooi CY
%A Debray D
%A Downey DG
%A Eschenhagen P
%A Girodon E
%A Hickman G
%A Koitschev A
%A Nazareth D
%A Nick JA
%A Peckham D
%A VanDevanter D
%A Raynal C
%A Scheers I
%A Waller MD
%A Sermet-Gaudelus I
%A Castellani C
%A  
%J J Cyst Fibros
%V 23
%N 4
%D 2024 Jul 19
%M 38508949
%F 5.527
%R 10.1016/j.jcf.2024.03.008
%X This is the third paper in the series providing updated information and recommendations for people with cystic fibrosis transmembrane conductance regulator (CFTR)-related disorder (CFTR-RD). This paper covers the individual disorders, including the established conditions - congenital absence of the vas deferens (CAVD), diffuse bronchiectasis and chronic or acute recurrent pancreatitis - and also other conditions which might be considered a CFTR-RD, including allergic bronchopulmonary aspergillosis, chronic rhinosinusitis, primary sclerosing cholangitis and aquagenic wrinkling. The CFTR functional and genetic evidence in support of the condition being a CFTR-RD are discussed and guidance for reaching the diagnosis, including alternative conditions to consider and management recommendations, is provided. Gaps in our knowledge, particularly of the emerging conditions, and future areas of research, including the role of CFTR modulators, are highlighted.